Success Metrics

Clinical Success Rate
90.9%

Based on 10 completed trials

Completion Rate
91%(10/11)
Active Trials
2(13%)
Results Posted
70%(7 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_3
3
20%
Ph phase_4
7
47%
Ph phase_1
4
27%

Phase Distribution

4

Early Stage

0

Mid Stage

10

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
4(28.6%)
Phase 3Large-scale testing
3(21.4%)
Phase 4Post-market surveillance
7(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

76.9%

10 of 13 finished

Non-Completion Rate

23.1%

3 ended early

Currently Active

2

trials recruiting

Total Trials

15

all time

Status Distribution
Active(2)
Completed(10)
Terminated(3)

Detailed Status

Completed10
Recruiting2
Withdrawn2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
2
Success Rate
90.9%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (28.6%)
Phase 33 (21.4%)
Phase 47 (50.0%)

Trials by Status

recruiting213%
terminated17%
completed1067%
withdrawn213%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT04434664Phase 4

BLOCKade of Calcium Channels and Beta Adrenergic Receptors for the Treatment of Hypertension in HFpEF

Completed
NCT04974138Phase 4

China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)

Recruiting
NCT04974151Phase 4

China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype

Recruiting
NCT00841815Phase 1

Amlodipine 10 mg Tablets Under Fed Conditions

Completed
NCT00841542Phase 1

Amlodipine 10 mg Tablets Under Fasting Conditions

Completed
NCT05275907Phase 4

Mechanism of Hypertension Treatments in Liver Transplant Recipients (BLOCK LTR-HTN)

Withdrawn
NCT02940548Phase 4

Nifedipine GITS and Amlodipine Besylate on Recovery of Blood Pressure Rhythm and Arterial Stiffness

Terminated
NCT00412113Phase 4

A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk

Completed
NCT03722381

Evaluation of Amlodipine Pharmacokinetics in Patients Receiving Hi Flux Hemodialysis

Withdrawn
NCT01302691Phase 3

MK-0954E Study in Participants With Hypertension (MK-0954E-357)

Completed
NCT02353806Phase 4

Pharmacokinetics of Amlodipine Besylate at Delivery and During Lactation

Completed
NCT01556997Phase 3

Perindopril Amlodipine for the Treatment of Hypertension

Completed
NCT00932763Phase 1

Study to Evaluate the Bioavailability of the Test Formulation of Amlodipine 10 mg Tablets (Torrent Pharmaceuticals Limited) Compared to a 10 mg Dose of Norvasc® (Pfizer) in 22 Fasted, Healthy Adult Subjects

Completed
NCT00932880Phase 1

Study to Evaluate the Bioavailability of the Test Formulation of Amlodipine 10 mg Tablets (Torrent Pharmaceuticals Limited) Compared to a 10 mg Dose of Norvasc® (Pfizer) in 18 Fed, Healthy Adult Subjects

Completed
NCT00289406Phase 3

Efficacy and Safety Study of S-Amlodipine Gentisate Compared to Amlodipine Besylate to Treat Mild-to-Moderate Hypertension

Completed

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15